Publications
-
Huerta-Ramos ME, Labad J, Cobo JV, Nuñez C, Creus M, García-Parés G, Cuadras-Palleja D, Franco J, Miquel E, Reyes JC, Marcó-García S, RALOPSYCAT Group and Usall J.
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
European archives of psychiatry and clinical neuroscience . 270(6): 729-737. Number of citations: 16
-
Tost M, Monreal JA, Armario A, Barbero JD, Cobo JV, García-Rizo C, Bioque M, Usall J, Huerta-Ramos ME, Soria V, PNECAT Group and Labad J.
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.
CLINICAL DRUG INVESTIGATION . 40(1): 1-14. Number of citations: 33
-
Vila E, Huerta-Ramos ME, Nuñez C, Usall J and Ramos B.
Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
European archives of psychiatry and clinical neuroscience . 269(8): 941-948. Number of citations: 6
-
Marco-Garcia S, Ferrer-Quintero M, Usall J, Ochoa S, del Cacho N and Huerta-Ramos ME.
Reconocimiento facial de emociones en trastornos neurologicos: una revision narrativa.
REVISTA DE NEUROLOGIA . 69(5): 207-219. Number of citations: 20
-
Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.
Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.
EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Number of citations: 12
-
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
BMJ Open . 8(7): . Number of citations: 8
-
Soria V, González-Rodríguez A, Huerta-Ramos ME, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group and Labad J.
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
PSYCHONEUROENDOCRINOLOGY . 93: 8-19. Number of citations: 51
-
Butjosa A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.
Development and validation of the Questionnaire of Stressful Life Events (QSLE).
JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Number of citations: 9
-
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Number of citations: 4
-
Butjosa A, Gómez-Benito J, Huerta-Ramos ME, del Cacho N, Barajas A, Baños I, Usall J, Dolz M, Sánchez Fernández B, Carlson J, Haro JM, GENIPE group and Ochoa S.
Incidence of stressful life events and influence of sociodemographic and clinical variables on the onset of first-episode psychosis.
PSYCHIATRY RESEARCH . 245: 108-115. Number of citations: 14